Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118280) titled 'Oral Health, Saliva Viscosity and Composition in Oculo-Pharyngeal Muscular Dystrophy (OPMD)' on Aug. 5.

Study Type: Observational [Patient Registry]

Primary Sponsor: Sheba Medical Center

Condition: Oculopharyngeal Muscular Dystrophy

Recruitment Status: Recruiting

Date of First Enrollment: March 1, 2023

Target Sample Size: 100

Countries of Recruitment: Israel

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07118280

Published by HT Digital Content Services with permission from Health Daily Digest....